Quick Summary: On the heels of raising $210 million at a $3.5 billion valuation, OpenEvidence is the fastest-growing physician app in history, now ... From oncology to cardiology, AI platform OpenEvidence is helping physicians keep pace with medical breakthroughs while ...

Free Open Access Evidence Based 22197 -

On the heels of raising $210 million at a $3.5 billion valuation, OpenEvidence is the fastest-growing physician app in history, now ... From oncology to cardiology, AI platform OpenEvidence is helping physicians keep pace with medical breakthroughs while ... An information session on the My Health Record and the upcoming legislative changes that will establish new rules for sharing ...

Important details found

  • On the heels of raising $210 million at a $3.5 billion valuation, OpenEvidence is the fastest-growing physician app in history, now ...
  • From oncology to cardiology, AI platform OpenEvidence is helping physicians keep pace with medical breakthroughs while ...
  • An information session on the My Health Record and the upcoming legislative changes that will establish new rules for sharing ...
  • Great Debate at the 2019 General Assembly of the European Geosciences Union (EGU), which took place in Vienna from 7 to 12 ...
  • The Microbiology Society is expanding its Publish and Read programme, aiming to help more researchers participate in and ...

Why this topic is useful

This topic is useful when readers need a quick overview first, then want to move into supporting details and related references.

Sponsored

Frequently Asked Questions

Why are related topics included?

Related topics help readers compare nearby references and understand the broader subject.

What is this page about?

This page summarizes Free Open Access Evidence Based 22197 and connects it with related entries, references, and supporting context.

Is the information always complete?

Not always. Some topics may need verification from official or primary sources.

Supporting Images

Free, Open Access, Evidence-Based Articles for Breast Reconstruction Patients
Supporting authors with fee-free Open Access | Publish and Read
Better and Faster Access Initiative - Sharing Reports with My Health Record by Default - 12 Feb 2026
Open disclosure– the essentials
OpenEvidence Co-founder & CTO Zack Ziegler
Open access to health research: WHO joins cOAlition S
EGU19: Plan-S: Should scientific publishers be forced to go Open Access? (GDB5)
Publishing Your Research 101 - Episode 7: Open Access and ACS AuthorChoice
Why Doctors Say OpenEvidence Is A ‘Game Changer’
Navigating NHMRC/MRFF Open Science Policy Changes with ARDC and ACTA: Clinical Trials
Sponsored
View Full Details
Free, Open Access, Evidence-Based Articles for Breast Reconstruction Patients

Free, Open Access, Evidence-Based Articles for Breast Reconstruction Patients

Dr Roy Kim of San Francisco Plastic Surgery and Dr. Minas Chrysopoulo of PRMA in San Antonio discuss the

Supporting authors with fee-free Open Access | Publish and Read

Supporting authors with fee-free Open Access | Publish and Read

The Microbiology Society is expanding its Publish and Read programme, aiming to help more researchers participate in and ...

Better and Faster Access Initiative - Sharing Reports with My Health Record by Default - 12 Feb 2026

Better and Faster Access Initiative - Sharing Reports with My Health Record by Default - 12 Feb 2026

An information session on the My Health Record and the upcoming legislative changes that will establish new rules for sharing ...

Open disclosure– the essentials

Open disclosure– the essentials

On Thursday 14 May the Aged Care Quality and Safety Commission held a webinar on

OpenEvidence Co-founder & CTO Zack Ziegler

OpenEvidence Co-founder & CTO Zack Ziegler

On the heels of raising $210 million at a $3.5 billion valuation, OpenEvidence is the fastest-growing physician app in history, now ...

Open access to health research: WHO joins cOAlition S

Open access to health research: WHO joins cOAlition S

Dr Soumya Swaminathan, Chief Scientist of the World Health Organization, and Dr Tedros Adhanom Ghebreyesus, WHO ...

EGU19: Plan-S: Should scientific publishers be forced to go Open Access? (GDB5)

EGU19: Plan-S: Should scientific publishers be forced to go Open Access? (GDB5)

Great Debate at the 2019 General Assembly of the European Geosciences Union (EGU), which took place in Vienna from 7 to 12 ...

Publishing Your Research 101 - Episode 7: Open Access and ACS AuthorChoice

Publishing Your Research 101 - Episode 7: Open Access and ACS AuthorChoice

Read more details and related context about Publishing Your Research 101 - Episode 7: Open Access and ACS AuthorChoice.

Why Doctors Say OpenEvidence Is A ‘Game Changer’

Why Doctors Say OpenEvidence Is A ‘Game Changer’

From oncology to cardiology, AI platform OpenEvidence is helping physicians keep pace with medical breakthroughs while ...

Navigating NHMRC/MRFF Open Science Policy Changes with ARDC and ACTA: Clinical Trials

Navigating NHMRC/MRFF Open Science Policy Changes with ARDC and ACTA: Clinical Trials

Read more details and related context about Navigating NHMRC/MRFF Open Science Policy Changes with ARDC and ACTA: Clinical Trials.